Fawzi Abu Rous, Medical Oncologist at Henry Ford Health, Committee member, ASCO Stage IV NSCLC Living Guideline Panel and ASCO Trainee Council, shared a post on LinkedIn:
“I enjoyed spending the weekend in Dubai representing Henry Ford Health at the 5th Annual International Oncology Forum. I had the opportunity to speak about the latest advances in HER2-mutated NSCLC, participate in interactive case discussions, and join a workshop on first-line treatment strategies for EGFR-mutated NSCLC.
The meeting brought together an outstanding faculty and colleagues from across the Middle East and beyond, leading to thoughtful discussions and practical, case-based learning.
Thank you to Dr. Fathi Azribi and Dr. Jawaher Ansari for the kind invitation and warm hospitality.
Looking forward to the next one.”
Other articles featuring Fawzi Abu Rous on OncoDaily.
